RELA and urinary bladder cancer: To confirm these results, we performed a series of tests on bladder cancer cell lines with pharmacological treatments, namely, PMA and PKC inhibitors Gö6976 and sotrastaurin, and measured p65 nuclear localization and NF-κB luciferase activity.